Zymeworks (ZYME) Cash & Equivalents (2021 - 2023)
Historic Cash & Equivalents for Zymeworks (ZYME) over the last 3 years, with Q3 2023 value amounting to $94.3 million.
- Zymeworks' Cash & Equivalents fell 182.14% to $94.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $94.3 million, marking a year-over-year decrease of 182.14%. This contributed to the annual value of $400.9 million for FY2022, which is 9860.2% up from last year.
- Latest data reveals that Zymeworks reported Cash & Equivalents of $94.3 million as of Q3 2023, which was down 182.14% from $142.1 million recorded in Q2 2023.
- Zymeworks' 5-year Cash & Equivalents high stood at $400.9 million for Q4 2022, and its period low was $94.3 million during Q3 2023.
- For the 3-year period, Zymeworks' Cash & Equivalents averaged around $186.1 million, with its median value being $161.8 million (2023).
- Per our database at Business Quant, Zymeworks' Cash & Equivalents skyrocketed by 9860.2% in 2022 and then crashed by 182.14% in 2023.
- Over the past 3 years, Zymeworks' Cash & Equivalents (Quarter) stood at $201.9 million in 2021, then surged by 98.6% to $400.9 million in 2022, then crashed by 76.47% to $94.3 million in 2023.
- Its Cash & Equivalents was $94.3 million in Q3 2023, compared to $142.1 million in Q2 2023 and $181.6 million in Q1 2023.